SCHEMBL13097162

SCHEMBL13097162

Cc1c(COc2ccc3c(c2)CCN(C(=O)CC2CCOCC2)C3)nc2ccc(F)cc2c1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.46
CHRM4 P08173 1/20 0.38
HRH3 Q9Y5N1 5/20 0.38
LMNA P02545 2/20 0.38
CYP2D6 P10635 2/20 0.38
HRH1 P35367 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NAMPT P43490 1/20 0.37
GRM5 P41594 1/20 0.37
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
NMT2 O60551 1/20 0.37
NMT1 P30419 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13097196 0.97 RORC (0.46) RORCHRH3LMNACYP2D6HRH1
SCHEMBL13107111 0.91 CHRM4 (0.38) RORCCHRM4NAMPTGRM5L3MBTL1
SCHEMBL13097203 0.90 CHRM4 (0.46) RORCCHRM4HRH3LMNAKDM4E
SCHEMBL13097201 0.90 PTGDR2 (0.42) RORCLMNAGRM5CNR1CNR2
SCHEMBL13107117 0.88 RORC (0.37) RORCCHRM4HRH3GRM5L3MBTL1
SCHEMBL13097194 0.88 RORC (0.45) RORCCHRM4HRH3LMNAKDM4E
SCHEMBL13097191 0.86 RORC (0.42) RORCLMNAKDM4EMAPTHPGD
SCHEMBL13097144 0.84 RORC (0.43) RORCLMNAKDM4EMAPTHPGD
SCHEMBL13097130 0.83 RORC (0.43) RORCLMNAKDM4EMAPTHPGD
SCHEMBL13106289 0.82 S1PR5 (0.39) RORCLMNANAMPTGRM5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367702-B2 Quinolone derivative ASTELLAS PHARMA INC. (JP) 2013-02-05 US disclosed
US-20100256113-A1 QUINOLONE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256113-A1 QUINOLONE DERIVATIVE NQO1, NQO2, NADK RORC 1412/4885CHRM4 1865/4885HRH3 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.